ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2019

Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153).

David R Spigel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.